NCT02218021View on ClinicalTrials.gov

A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

Samidorphan

DRUG

Placebo

DRUG

Oxycodone

Trial Locations (1)

66212

Alkermes Investigational Site, Overland Park

Sponsors

Lead Sponsor

Alkermes, Inc.
All Listed Sponsors
lead

Alkermes, Inc.

INDUSTRY